Immunomedics Inc Receivables Turnover Ratio (IMMU), from the second quarter 2020 to the second quarter 2019 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Immunomedics Inc   (NASDAQ: IMMU)
 

Immunomedics Inc Accounts Receivables Turnover Ratio from the second quarter 2020 to the second quarter 2019

Quarterly Results, Trends, Rankings, Statistics


Immunomedics Inc 's ability to collect accounts receivable sequentially worsen to 3.61, indicating more challenging environment then in the first quarter 2020, but still, it is a far cry from any concerns. Immunomedics Inc 's Accounts Receivable average collection period in the Jun 30 2020 quarter, has increased to 101 days, from 91 days, in the Mar 31 2020 quarter.

If we take a look into Healthcare sector Immunomedics Inc achieved the highest receivable turnover ratio. While receivables turnover ratio remained unchanged relative to the previous period at no. .

What is Receivable Turnover Ratio?
What is Immunomedics Inc Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

IMMU Receivables Turnover Ratio (Jun 30 2020)
II. Quarter		 (Mar 31 2020)
I. Quarter		 (Dec 31 2019)
IV. Quarter		 (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter
Y / Y Receivable Change - - - - -
Y / Y Revenue Change - - -72.6 % - -
Receivable Turnover Ratio (TTM) 3.61 4 4 - -
IMMU's Total Ranking # # # # #
Accounts Receivable average collection period days 101 91 91 - -
Seq. Receivable Change - - - - -
Seq. Revenue Change - - - - -


Receivable Turnover Company Ranking
Within: No.
In Vitro & In Vivo Diagnostic Substances Industry #
Healthcare Sector #
Overall Market #

Receivable Turnover Ratio Statistics
High Average Low
0 0 0
 





IMMU Company Profile • Back to IMMU Efficiency Comparisons • Compare IMMU Receivables Turnover Ratio to its Competitors

Financial Statements
Immunomedics Inc 's Accounts Receivable $ 22 Millions Visit IMMU's Balance sheet
Immunomedics Inc 's Sales TTM $ 20 Millions Visit IMMU's Income Statement
Sources of IMMU's Revenues Visit IMMU's Sales by Geography

Other Accounts Receivable Turnover Ratios
In Vitro & In Vivo Diagnostic Substances Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
IMMU's Receivable Turnover Ratio versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
IMMU's Growth Rates IMMU's Roa IMMU's Inventory Turnover Ratio IMMU's Dividend Comparisons
IMMU's Profitability Ratios IMMU's Roi IMMU's Asset Turnover Ratio IMMU's Dividend Growth
IMMU's Valuation Ratios IMMU's Roe IMMU's Financial Strength Ratios IMMU's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2020, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Jun 30 2020 Receivable at quarter ending Jun 30 2020
Viewray Inc   2.52 $ 65.805  Millions$ 26.149  Millions
Interpace Biosciences Inc   2.51 $ 26.445  Millions$ 10.519  Millions
Electromed Inc   2.51 $ 32.471  Millions$ 12.927  Millions
Bionik Laboratories Corp   2.49 $ 1.621  Millions$ 0.650  Millions
American Shared Hospital Services  2.47 $ 15.362  Millions$ 6.216  Millions
Statera Biopharma Inc fka Cytocom Inc   2.28 $ 0.667  Millions$ 0.293  Millions
Eyepoint Inc   2.17 $ 22.754  Millions$ 10.491  Millions
Nabriva Therapeutics Plc  2.14 $ 8.529  Millions$ 3.995  Millions
Biospecifics Technologies Corp  2.10 $ 34.778  Millions$ 16.571  Millions
Aerie Pharmaceuticals Inc   2.07 $ 81.575  Millions$ 39.413  Millions
Biora Therapeutics Inc   1.95 $ 17.901  Millions$ 9.188  Millions
Xeris Biopharma Holdings Inc   1.92 $ 5.403  Millions$ 2.817  Millions
Sensus Healthcare Inc   1.89 $ 17.213  Millions$ 9.108  Millions
Cardiff Oncology Inc   1.78 $ 0.255  Millions$ 0.143  Millions
Biocept Inc   1.75 $ 5.677  Millions$ 3.247  Millions
Bionano Genomics Inc   1.71 $ 8.420  Millions$ 4.925  Millions
Regenxbio Inc   1.68 $ 60.678  Millions$ 36.180  Millions
American Cryostem Corporation  1.65 $ 0.582  Millions$ 0.352  Millions
Dicerna Pharmaceuticals Inc   1.64 $ 89.591  Millions$ 54.603  Millions
Regen Biopharma Inc   1.50 $ 0.110  Millions$ 0.073  Millions
Lexaria Bioscience Corp   1.50 $ 0.384  Millions$ 0.257  Millions
Edesa Biotech Inc   1.34 $ 0.157  Millions$ 0.117  Millions
Lannett Company Inc  1.24 $ 197.236  Millions$ 159.413  Millions
Navidea Biopharmaceuticals Inc   1.14 $ 0.783  Millions$ 0.686  Millions
Intelgenx Technologies Corp   1.08 $ 0.373  Millions$ 0.346  Millions
Kazia Therapeutics Limited  1.07 $ 0.995  Millions$ 0.932  Millions
Wave Life Sciences Ltd   0.72 $ 12.517  Millions$ 17.500  Millions
Kala Bio inc   0.65 $ 4.535  Millions$ 6.952  Millions
Palisade Bio Inc   0.46 $ 0.014  Millions$ 0.030  Millions
Revance Therapeutics Inc   0.39 $ 0.492  Millions$ 1.262  Millions

Date modified: 2026-09-08T15:10:00+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.